Patient characteristics, n = 29
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 65 (32-84) |
| Female:male | 13:16 |
| Diagnosis, no. (%) | |
| AML | 22 (75.9) |
| MDS | 5 (17.2) |
| ALL | 1 (3.4) |
| CML | 1 (3.4) |
| Median baseline WBC, ×109/L (range) | 5.7 (0.3-57.8) |
| Cytogenetics, n (%) | |
| Diploid | 11 (39) |
| Other | 15 (47) |
| t(8;21) | 2 (8) |
| t(9;22) | 1 (4) |
| Prior treatment | |
| Median (range) | 2 (0-5) |
| Untreated (%) | 5 (17) |
| 1 (%) | 8 (28) |
| 2 or more (%) | 16 (55) |
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 65 (32-84) |
| Female:male | 13:16 |
| Diagnosis, no. (%) | |
| AML | 22 (75.9) |
| MDS | 5 (17.2) |
| ALL | 1 (3.4) |
| CML | 1 (3.4) |
| Median baseline WBC, ×109/L (range) | 5.7 (0.3-57.8) |
| Cytogenetics, n (%) | |
| Diploid | 11 (39) |
| Other | 15 (47) |
| t(8;21) | 2 (8) |
| t(9;22) | 1 (4) |
| Prior treatment | |
| Median (range) | 2 (0-5) |
| Untreated (%) | 5 (17) |
| 1 (%) | 8 (28) |
| 2 or more (%) | 16 (55) |
AML indicates acute myelogenous leukemia; MDSs, myelodysplastic syndromes; ALL, acute lymphocytic leukemia; and CML, chronic myelogenous leukemia.